HyperBranch Medical Technology, a developer of wound and surgical sealants, has raised nearly $1.8 million in new financing, according to an SEC filing.

The money was raised over the past two weeks.

In the filing, HyperBranch says it hopes to raise another $95,000.

HyperBranch, which is based in Durham, raised the funds as equity.

The company recently received a CE Mark for an applicator that delivers its sealant used in cranial and spinal surgeries.

HyperBranch is still seeking U.S. Food and Drug Administration approval of the system.

(MedCity News contributed to this report.)